首页/数据集/Transcription profiling by array of human OCI-AML cells treated with maesopsin glucoside

Transcription profiling by array of human OCI-AML cells treated with maesopsin glucoside

ChEBI2011-02-07 更新2026-07-21 收录

白血病药物反应

微阵列转录组学

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-MEXP-3088 数据链接链接失效反馈

官方服务：

资源简介：

Transcription profiling by array of human OCI-AML cells treated with maesopsin glucoside

应用场景：

创建时间：

2011-02-07

果蝇形态发生基因表达

微阵列转录组学

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

NIAID Data Ecosystem50

A novel regulatory mechanism of U2 spliceosome proteostasis that controls the transcriptome and therapy response in cancer [RNAseq_CUTLL1_E7107_24hr]

癌症剪接调控

白血病药物反应

Aberrant splicing is an important cause of cancer, and the production of noncanonical, cancer-specific, mRNA transcripts associate with transformation. Studies have focused on characterizing the effec

NIAID Data Ecosystem30

OCI-AML-21 + KPT-9274 RNA-Seq-Processed file- FPKM count

白血病药物反应

转录组生物标记物分析

This Excel file contains processed data as FPKM count. The counts are generated from different fraction of OCI-AML-21 cells based on CD34 and CD38 surface markers after treatment with KPT-9274

Mendeley Data2021-06-21 更新10

Imatinib Treatment Induces CD5+ B Lymphocytes and IgM Natural Antibodies with Anti-Leukemic Reactivity in Patients with Chronic Myelogenous Leukemia

肿瘤免疫治疗

白血病药物反应

Imatinib mesylate is a first line treatment of Chronic Myelogenous Leukemia and of a rare form of gastrointestinal stromal cancer, where the response to the drug is also linked to the immune system ac

NIAID Data Ecosystem40

Additional file 18 of Comparative preclinical drug response analyses of T-prolymphocytic leukemia reveal no differences between known gene expression subgroups

白血病药物反应

基因表达亚型分析

Supplementary Material 18

Figshare2025-10-27 更新10